24/7 Wall St. normally covers research and analyst calls each morning of the week.  After reviewing these, there always turn out to be some insightful research calls that stand well apart from the crowd of routine upgrades and downgrades.  Some may even be dubious calls or may be very negative research expectations on a company. 

The top analyst calls of this last week were in shares of Apple Inc. (NASDAQ: AAPL), C
isco Systems Inc. (NASDAQ: CSCO), Fusion-io Inc. (NYSE: FIO), Human Genome Sciences Inc. (NASDAQ: HGSI), LinkedIn Corporation (NYSE: LNKD), Monsanto Co. (NYSE: MON), NetApp Inc. (NASDAQ: NTAP), Netflix. Inc. (NASDAQ: NFLX), Riverbed Technology, Inc. (NASDAQ: RVBD), and finally in The Talbots Inc. (NYSE: TLB).

We have included the rating summary and a brief description on each call, as well as having added color or given background data on each if applicable.

Apple Inc. (NASDAQ: AAPL) blew the doors off the hinges but there was one new call which stood out.  Brian White of Ticonderoga became the “street high” target with a $666 price target. That will make it the biggest market cap of all companies and then some if it comes about.

Cisco Systems Inc. (NASDAQ: CSCO) was an interesting call from Argus this week with a very high price target.  The firm reiterated a Buy and a $24 target, implying close to 50% upside in the largest networking equipment player.  It seems hard to fathom, but that was one call after the restructuring news.

Fusion-io Inc. (NYSE: FIO) saw its post-IPO quiet period end earlier this last week.  The rating initiations were as follows:

• Started as Outperform at Credit Suisse;
• Started as Neutral at Goldman Sachs;
• Started as Equal-Weight at Morgan Stanley;
• Started as Neutral at JPMorgan.

Human Genome Sciences Inc. (NASDAQ: HGSI) had nothing short of a just awful week as it was deemed that Benlysta sales were soft.  Shares hit a 52-week low on Friday of $21.21.  Leerink Swann defended the stock with a “buy on weakness” call on Friday afternoon.